Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsIngo K. Mellinghoff, Paul S. Mischel, Maria Y. Wang et al.|New England Journal of Medicine|2005Cited by 1.4k
Artificial intelligence in radiation oncologyElizabeth Huynh, Raymond H. Mak, Steven Petit et al.|Nature Reviews Clinical Oncology|2020Cited by 399
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, William A. Weiss, Matthias A. Karajannis et al.|Neuro-Oncology|2016Cited by 365
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in GlioblastomaQi-Wen Fan, William A. Weiss, Ozlem Aksoy et al.|Cancer Cell|2017Cited by 182
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomideGautam Prasad, Daphne A. Haas‐Kogan|Neuro-Oncology|2011Cited by 158